GH Research (GHRS) Times Interest Earned (2021 - 2025)
GH Research's (GHRS) quarterly Times Interest Earned came in at $93.39 in Q4 2025, up 29.15% year-on-year from $72.31 in Q4 2024, and down 88.16% quarter-over-quarter from $788.81 in Q3 2025.
GH Research (GHRS) Times Interest Earned (2021 - 2025) Analysis & Trends
GH Research's Times Interest Earned history runs 5 years deep, the most recent figure standing at $93.39 for Q4 2025.
- On a quarterly basis, Times Interest Earned rose 29.15% year-over-year to $93.39 in Q4 2025; TTM through Dec 2025 was $110.0, a 56.76% increase from a year earlier, with the FY2025 full-year figure at $95.02, up 36.55% from the prior year.
- Times Interest Earned eased to $93.39 in Q4 2025 per GHRS's latest filing, from $788.81 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1555.3 in Q3 2021 and bottomed at -$416.91 in Q4 2022.
- The 5-year median for Times Interest Earned is $70.63 (2024), against an average of $167.23.
- Across the five-year window, Times Interest Earned fell 13.34% in 2022 and jumped 1031.25% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$367.83 in 2021, then fell by 13.34% to -$416.91 in 2022, then jumped by 97.6% to -$10.02 in 2023, then soared by 821.9% to $72.31 in 2024, then increased by 29.15% to $93.39 in 2025.
- Per Business Quant, the three latest GHRS Times Interest Earned figures stand at $93.39 (Q4 2025), $788.81 (Q3 2025), and $84.51 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | 93.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 93.39 |
| Sep 30, 2025 | 788.81 |
| Jun 30, 2025 | 84.51 |
| Mar 31, 2025 | 71.53 |
| Dec 31, 2024 | 72.31 |
| Sep 30, 2024 | 69.73 |
| Jun 30, 2024 | 74.26 |
| Mar 31, 2024 | 64.40 |
| Dec 31, 2023 | -10.02 |
| Sep 30, 2023 | 52.82 |
| Jun 30, 2023 | 55.45 |
| Mar 31, 2023 | 42.35 |
| Dec 31, 2022 | -416.91 |
| Dec 31, 2021 | -367.83 |
| Sep 30, 2021 | 1,555.33 |
| Jun 30, 2021 | 445.50 |